SLC23A2
Basic information
Region (hg38): 20:4852356-5010293
Previous symbols: [ "SLC23A1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC23A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 19 | 2 | 6 |
Variants in SLC23A2
This is a list of pathogenic ClinVar variants found in the SLC23A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-4856979-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
20-4857126-G-A | not specified | Uncertain significance (Aug 16, 2022) | ||
20-4857139-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
20-4857171-T-C | not specified | Uncertain significance (Dec 22, 2023) | ||
20-4857181-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
20-4867829-C-A | not specified | Uncertain significance (Jun 22, 2023) | ||
20-4869923-G-T | Likely benign (Jun 23, 2018) | |||
20-4869993-A-T | not specified | Uncertain significance (Apr 09, 2024) | ||
20-4869998-G-A | Benign (Jan 03, 2019) | |||
20-4873958-C-A | Benign (Jul 23, 2018) | |||
20-4874607-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
20-4874663-G-A | Benign (Dec 31, 2019) | |||
20-4883652-T-C | not specified | Uncertain significance (Dec 03, 2021) | ||
20-4883680-C-T | Benign (Jul 23, 2018) | |||
20-4884757-C-T | not specified | Uncertain significance (Jul 11, 2023) | ||
20-4884776-T-A | not specified | Uncertain significance (Jun 28, 2022) | ||
20-4885830-T-C | not specified | Uncertain significance (Oct 12, 2022) | ||
20-4899545-C-T | Benign (Mar 31, 2018) | |||
20-4902489-T-C | not specified | Uncertain significance (May 11, 2022) | ||
20-4902509-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
20-4902521-A-G | not specified | Uncertain significance (Jun 24, 2022) | ||
20-4902554-G-A | not specified | Uncertain significance (Jun 02, 2024) | ||
20-4912894-C-T | not specified | Uncertain significance (May 27, 2022) | ||
20-4912902-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
20-4912905-G-C | not specified | Uncertain significance (May 06, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC23A2 | protein_coding | protein_coding | ENST00000379333 | 15 | 157938 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00626 | 0.994 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.63 | 190 | 393 | 0.484 | 0.0000230 | 4203 |
Missense in Polyphen | 68 | 180.94 | 0.37581 | 1976 | ||
Synonymous | -1.17 | 183 | 164 | 1.12 | 0.0000112 | 1336 |
Loss of Function | 3.61 | 10 | 32.1 | 0.312 | 0.00000159 | 364 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000353 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000132 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sodium/ascorbate cotransporter. Mediates electrogenic uptake of vitamin C, with a stoichiometry of 2 Na(+) for each ascorbate.;
- Pathway
- Vitamin C (ascorbate) metabolism;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Linoleate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.163
Intolerance Scores
- loftool
- 0.293
- rvis_EVS
- -0.93
- rvis_percentile_EVS
- 9.55
Haploinsufficiency Scores
- pHI
- 0.504
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.254
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc23a2
- Phenotype
- respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- nucleobase-containing compound metabolic process;sodium ion transport;nucleobase transport;L-ascorbic acid transmembrane transport;L-ascorbic acid metabolic process;transepithelial L-ascorbic acid transport
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane;basal plasma membrane;membrane;integral component of membrane;basolateral plasma membrane;apical plasma membrane
- Molecular function
- transporter activity;L-ascorbate:sodium symporter activity;nucleobase transmembrane transporter activity;L-ascorbic acid transmembrane transporter activity;sodium-dependent L-ascorbate transmembrane transporter activity